checkAd

     112  0 Kommentare GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors - Seite 4

    References

    1. Centers for Disease Control and Prevention website. Sickle Cell Disease (SCD). https://www.cdc.gov/ncbddd/sicklecell/data.html. Accessed June 3, 2019.
    2. European Medicines Agency. https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu318 .... Accessed June 12, 2020.
    3. National Heart, Lung, and Blood Institute website. Sickle Cell Disease. https://www.nhlbi.nih.gov/health-topics/sickle-cell-disease. Accessed August 5, 2019.
    4. Rees DC, et al. Lancet. 2010;376(9757):2018-2031.
    5. Kato GJ, et al. Nat Rev Dis Primers. 2018;4:18010.
    6. Kato GJ, et al. J Clin Invest. 2017;127(3):750-760.
    7. Caboot JB, et al. Paediatr Respir Rev. 2014;15(1):17-23.

    Contact:
    Steven Immergut (media)
    650.410.3258
    simmergut@gbt.com

    Courtney Roberts (investors)
    650.351.7881
    croberts@gbt.com


    Seite 4 von 4




    globenewswire
    0 Follower
    Autor folgen

    Verfasst von globenewswire
    GBT Appoints Alexis A. Thompson, M.D., M.P.H., to Board of Directors - Seite 4 SOUTH SAN FRANCISCO, Calif., March 18, 2021 (GLOBE NEWSWIRE) - Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced the appointment of Alexis A. Thompson, M.D., M.P.H., a world-renowned hematologist and sickle cell disease (SCD) …